Page last updated: 2024-09-04

homocysteine-thiolactone-2-chloronicotinamide and phenylephrine

homocysteine-thiolactone-2-chloronicotinamide has been researched along with phenylephrine in 1 studies

Compound Research Comparison

Studies
(homocysteine-thiolactone-2-chloronicotinamide)
Trials
(homocysteine-thiolactone-2-chloronicotinamide)
Recent Studies (post-2010)
(homocysteine-thiolactone-2-chloronicotinamide)
Studies
(phenylephrine)
Trials
(phenylephrine)
Recent Studies (post-2010) (phenylephrine)
90613,7978572,083

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janković, G; Kostić-Rajačić, S; Rizvić, E; Savić, MM1

Other Studies

1 other study(ies) available for homocysteine-thiolactone-2-chloronicotinamide and phenylephrine

ArticleYear
Atypical sympathomimetic drug lerimazoline mediates contractile effects in rat aorta predominantly by 5-HT2A receptors.
    Bosnian journal of basic medical sciences, 2017, Aug-20, Volume: 17, Issue:3

    Topics: Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Phenylephrine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Serotonin Antagonists; Sympathomimetics; Vasoconstrictor Agents

2017